In more recent literature, a more nuanced point of view has emerged recognizing the specific impact of proliferating CD8+ T cells and/or the ratio of CD8+/CD4+ T cells on survival in patients with GBM (57, 58), supporting a necessary balance within the cellular immune response in GBM to improve current treatment strategies. Here, CD8A is linked to glioblastoma.